Endobiliary Radiofrequency Ablation in Cholangiocarcinoma: Current Evidence and Future Perspectives
Journal of Clinical Medicine · 23.07.2026 · 15 (15) · 5781
DOI: 10.3390/jcm15155781 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.07.2026. Verfasst von Razan Aburumman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Henry Ford Hospital, Detroit, MI 48202, USA. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cholangiocarcinoma (CCA) is an aggressive malignancy associated with malignant biliary obstruction and it has poor overall survival. Most patients present with unresectable disease which limits curative treatment options and highlights the need for effective palliative therapies. Endobiliary radiofrequency ablation (RFA) has emerged as a minimally invasive technique aimed at reducing intraductal tumor burden, improving biliary drainage, and potentially prolonging survival. Recently, multiple randomized controlled trials, retrospective studies, and meta-analyses have evaluated the role of endobiliary RFA in patients with CCA, with mixed results. Available evidence suggests that RFA may provide a survival benefit in selected patients. However, its effects on stent patency and quality of life remain inconsistent across studies. Current data also demonstrate an overall acceptable safety profile. In this review, we summarize the procedural techniques, currently available evidence, adverse events, patient selection considerations, guideline recommendations, and future directions regarding the use of endobiliary RFA in CCA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Henry Ford Hospital, Detroit, MI 48202, USA.
- Division of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI 48202, USA.
ORCID-Profile: Razan Aburumman
Zitieren
APA
Aburumman, R., Faisal, M. S., & Singla, S. (2026). Endobiliary Radiofrequency Ablation in Cholangiocarcinoma: Current Evidence and Future Perspectives. Journal of Clinical Medicine, 15(15), 5781. https://doi.org/10.3390/jcm15155781
Vancouver
Aburumman R, Faisal MS, Singla S. Endobiliary Radiofrequency Ablation in Cholangiocarcinoma: Current Evidence and Future Perspectives. Journal of Clinical Medicine. 2026;15(15):5781. doi:10.3390/jcm15155781
BibTeX
@article{Aburumman2026,
author = {Aburumman, Razan and Faisal, Muhammad Saad and Singla, Sumit},
title = {Endobiliary Radiofrequency Ablation in Cholangiocarcinoma: Current Evidence and Future Perspectives},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {15},
pages = {5781},
doi = {10.3390/jcm15155781}
}
EUVIMED